PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine

Pharmaceutical Research

Volumn 19, Issue 10, 2002, Pages 1417-1423

  Naruhashi, Kazumasa ^a   Sai, Yoshimichi ^a   Tamai, Ikumi ^a   Suzuki, Nagao ^a   Tsuji, Akira ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cefadroxil; Intestine; mRNA; PepT1; Transport

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARRIER PROTEIN; CEFADROXIL; MESSENGER RNA; PEPTIDE TRANSPORTER 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVICE; DRUG ABSORPTION; DRUG TRANSPORT; EVALUATION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE ABSORPTION; STARVATION;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CEFADROXIL; GENE EXPRESSION REGULATION; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STARVATION; SYMPORTERS;

EID: 0036804570     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020436028194     Document Type: Article

References (30)

1. A. Tsuji and I. Tamai. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13:963-977 (1996).
2. Y. J. Fei, Y. Kanai, S. Nussberger, V. Ganapathy, F. H. Leibach, M. F. Romero, S. K. Singh, W. F. Boron, and M. A. Hediger. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368:563-566 (1994).
3. +/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J. Biol. Chem. 270:6456-6463 (1995).
4. +/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. J. Pharmacol. Exp. Ther. 275:1631-1637 (1995).
5. K. Miyamoto, T. Shiraga, K. Morita, H. Yamamoto, H. Haga, Y. Taketani, I. Tamai, Y. Sai, A. Tsuji, and E. Takeda. Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter. Biochim. Biophys. Acta 1305:34-38 (1996).
6. Y. J. Fei. M. Sugawara, J. C. Liu, H. W. Li, V. Ganapathy, M. E. Ganapathy, and F. H. Leibach. cDNA structure, genomic organization, and promoter analysis of the mouse intestinal peptide transporter PEPT1. Biochim. Biophys. Acta 1492:145-154 (2000).
7. I. Tamai, N. Tomizawa, A. Kadowaki, T. Terasaki, K. Nakayama, H. Higashida, and A. Tsuji. Functional expression of intestinal dipeptide/beta-lactam antibiotic transporter in Xenopus laevis oocytes. Biochem. Pharmacol. 48:881-888 (1994).
8. +/peptide cotransporter PEPT1: Localization of PEPT1 and transport of beta-lactam antibiotics. J. Pharmacol. Exp. Ther. 281:1415-1421 (1997).
9. I. Tamai, N. Tomizawa, T. Takeuchi, K. Nakayama, H. Higashida, and A. Tsuji. Functional expression of transporter for beta-lactam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestines. J. Pharmacol. Exp. Ther. 273:26-31 (1995).
10. I. Tamai, T. Nakanishi, K. Hayashi, T. Terao, Y. Sai, T. Shiraga, K. Miyamoto, E. Takeda, H. Higashida, and A. Tsuji. The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine. J. Pharm. Pharmacol. 49:796-801 (1997).
11. X. Y. Chu, G. P. Sanchez-Castano, K. Higaki, D. M. Oh, C. P. Hsu, and G. L. Amidon. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter. J. Pharmacol. Exp. Ther. 299:575-582 (2001).
12. R. H. Erickson and J. R. Gum, Jr., M. M. Lindstrom, D. McKean, and Y. S. Kim. Regional expression and dietary regulation of rat small intestinal peptide and amino acid transporter mRNAs. Biochem. Biophys. Res. Commun. 216:249-257 (1995).
13. +/peptide transporter PepT1. Gastroenterology 116:354-362 (1999).
14. H. Ogihara, T. Suzuki, Y. Nagamachi, K. Inui, and K Takata. Peptide transporter in the rat small intestine: Ultrastructural localization and the effect of starvation and administration of amino acids. Histochem. J. 31:169-174 (1999).
15. H. Tanaka, K I. Miyamoto, K. Morita, H. Haga, H. Segawa, T. Shiraga, A. Fujioka, T. Kouda, Y. Taketani, S. Hisano, Y. Fukui, K. Kitagawa, and E. Takeda. Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury. Gastroenterology 114:714-723 (1998).
16. K. Naruhashi, M. Nadai, M. Nakao, N. Suzuki, T. Nabeshima, and T. Hasegawa. Changes in absorptive function of rat intestine injured by methotrexate. Clin. Exp. Pharmacol. Physiol. 27:980-986 (2000).
17. +/peptide transporter PEPT1 in the human intestinal cell line Caco-2. Biochem. Biophys. Res. Commun. 261:242-246 (1999).
18. M. Thamotharan, S. Z. Bawani, X. Zhou, and S. A. Adibi. Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line. Am. J. Physiol. 276:C821-826 (1999).
19. +/peptide cotransporter in rat digestive tract. Biochem. Biophys. Res. Commun. 220:848-852 (1996).
20. Y. Sai, I. Tamai, H. Sumikawa, K. Hayashi, T. Nakanishi, O. Amano, M. Numata, S. Iseki, and A. Tsuji. Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of beta-lactam antibiotics. FEBS Lett. 392:25-29 (1996).
21. C. T. Wittwer, K. M. Ririe, R. V. Andrew, D. A. David, R. A. Gundry, and U. J. Balis. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22:176-181 (1997).
22. K. Naruhashi, I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki, and A. Tsuji. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafioxacin in rats. Antimicrob. Agents Chemother. 46:344-349 (2002).
23. Z. Dische and E. Borenfreund. A new spectrophotometric method for the detection and determination of keto sugars and trioses. J. Biol. Chem. 192:583-587 (1951).
24. T. Sawamoto, S. Haruta, Y. Kurosaki, K. Higaki, and T. Kimura. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability. J. Pharm. Pharmacol. 49:450-457 (1997).
25. C. Y. Yang, A. H. Dantzig, and C. Pidgeon. Intestinal peptide transport systems and oral drug availability. Pharm. Res. 16:1331-1343 (1999).
26. T. Terada, K. Sawada, H. Saito, Y. Hashimoto, and K. Inui. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am. J. Physiol. 276:G1435-G1441 (1999).
27. M. Irie, T. Terada, K. Sawada, H. Saito, and K. Inui. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells. J. Pharmacol. Exp. Ther. 298:711-717 (2001).
28. Y. Tomita, M. Takano, M. Yasuhara, R. Hori, and K. Inui. Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells. J. Pharmacol. Exp. Ther. 272:63-69 (1995).
29. M. Thamotharan, S. Z. Bawani, X. Zhou, and S. A. Adibi. Functional and molecular expression of intestinal oligopeptide transporter (Pept-1) after a brief fast. Metabolism 48:681-684 (1999).
30. H. Maekawa, Y. Takagishi, K Iwamoto, Y. Doi, and T. Ogura. Cephalexin preparation with prolonged activity. Jpn. J. Antibiot. 30:631-638 (1977).